Association Between RAS/BRAF Mutations and Complete Response Following Total Neoadjuvant Therapy in Patients with Rectal Cancer: A Prospective Multicentered Study.

MLA

Bedrikovetski, Sergei, et al. “Association Between RAS/BRAF Mutations and Complete Response Following Total Neoadjuvant Therapy in Patients with Rectal Cancer: A Prospective Multicentered Study.” Annals of Surgical Oncology, vol. 31, no. 3, Mar. 2024, pp. 1681–89. EBSCOhost, https://doi.org/10.1245/s10434-023-14722-7.

APA

Bedrikovetski, S., Traeger, L., Fitzsimmons, T., Price, T. J., Ruszkiewicz, A. R., Vather, R., & Sammour, T. (2024). Association Between RAS/BRAF Mutations and Complete Response Following Total Neoadjuvant Therapy in Patients with Rectal Cancer: A Prospective Multicentered Study. Annals of Surgical Oncology, 31(3), 1681–1689. https://doi.org/10.1245/s10434-023-14722-7

Chicago

Bedrikovetski, Sergei, Luke Traeger, Tracy Fitzsimmons, Timothy J Price, Andrew R Ruszkiewicz, Ryash Vather, and Tarik Sammour. 2024. “Association Between RAS/BRAF Mutations and Complete Response Following Total Neoadjuvant Therapy in Patients with Rectal Cancer: A Prospective Multicentered Study.” Annals of Surgical Oncology 31 (3): 1681–89. doi:10.1245/s10434-023-14722-7.